The global flunarizine hydrochloride market is anticipated to grow at considerable CAGR during the forecast period (2022-2028). Flunarizine hydrochloride is a calcium antagonist that works to prevent or reduce migraine migraines. This medication is used to treat vertigo and dizziness. Flunarizine hydrochloride market growth is fueled by rising migraine prevalence, increased intake of junk food, smoking and drinking, and a hectic and stressful lifestyle that leads to migraines. Further, the calcium channel, voltage-gated subunit beta-type (CACNB) gene is studied using flunarizine hydrochloride in research. Flunarizine inhibits the translation of CACNB mRNA, lowering the protein's expression. The effect of calcium channel, voltage-gated subunit beta-type encoded protein in neuronal development is being studied with this medication. Flunarizine inhibits the translation of CACNB mRNA, lowering the protein's expression.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/flunarizine-hydrochloride-market
The presence of alternatives is restraining the growth of global flunarizine hydrochloride market. For instance, in May 2021, Biohaven Pharma has launched Nurtec Odt. Furthermore, US Food and Drug Administration has approved the drug in February 2021. The Nurtec is a calcitonin gene-related peptide receptor antagonist that is used to treat acute migraine and also prevents episodic migraine in adults. Moreover, according to the CEO of Biohaven pharma, the company reported $136 million in net product revenue from the sales of Nurtec Odt in the third quarter of 2021. The availability of various alternatives is anticipated to hamper the demand of global flunarizine hydrochloride market during the forecast period.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/flunarizine-hydrochloride-market
Impact of COVID-19 Pandemic on Global Flunarizine Hydrochloride Market.
The COVID-19 pandemic had resulted in a significant impact on the global economy as a whole. However, the COVID-19 pandemic has resulted in a decline in the growth of the global flunarizine hydrochloride market. The implementation of lockdown and restrictions has disrupted the supply chain which led to delayed business deals between the manufacturers and producers. Thus, owing to the strict regulations, the global flunarizine market has resulted in a significant decline.
Segmental Outlook
The global flunarizine hydrochloride market is segmented based on application and drug formulation. Based on the application, the market is further segmented into vertigo and migraine. Based on the drug formulation, the market is further sub-segmented into tablets and capsules. Among these, the migraine segment is anticipated to hold a considerable share in the market owing to the rise in the awareness of healthcare among the population.
by Application (Migraine and Vertigo)
by Drug Formulation (Tablets and Capsules)
Market Players Outlook
The major companies serving the global flunarizine hydrochloride market are Johnson & Johnson Services Inc., Cipla Ltd., Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd, and more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2019, Uberlvy received approval from Food and Drug Administration for Uberlvy. Uberlvy is a medicine developed by Allergan, used for the treatment of acute migraine attacks in adults.
The Report Covers
Market value data analysis of 2021 and forecast to 2028.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the flunarizine hydrochloride market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404